i-SENS, Inc. (KOSDAQ:099190)
16,550
-60 (-0.36%)
Sep 11, 2026, 3:30 PM KST
i-SENS Revenue
i-SENS had revenue of 88.67B KRW in the quarter ending June 30, 2026, with 15.48% growth. This brings the company's revenue in the last twelve months to 326.19B, up 6.64% year-over-year. In the year 2025, i-SENS had annual revenue of 315.44B with 8.35% growth.
Revenue (ttm)
326.19B
Revenue Growth
+6.64%
P/S Ratio
1.46
Revenue / Employee
348.12M
Employees
937
Market Cap
475.92B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 315.44B | 24.31B | 8.35% |
| Dec 31, 2024 | 291.14B | 26.02B | 9.81% |
| Dec 31, 2023 | 265.12B | 283.13M | 0.11% |
| Dec 31, 2022 | 264.84B | 31.90B | 13.70% |
| Dec 31, 2021 | 232.93B | 29.23B | 14.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SD Biosensor | 738.76B |
| Value Added Technology | 441.04B |
| InBody Co.,Ltd | 263.89B |
| T&L Co., Ltd. | 175.16B |
| WON TECH | 167.35B |
| BioNote | 126.41B |
| SEERS | 97.05B |
| Curexo | 77.74B |